| Literature DB >> 20551955 |
R Ali1, I Barnes, S W Kan, V Beral.
Abstract
BACKGROUND: Incidence rates for many cancers are lower in India than in Britain and it is therefore of interest to compare rates in British Indians to British whites, as well as to rates in India. We present estimates for Leicester, which has the largest population of Indian origin in Britain, and also has virtually complete, self-assigned, ethnicity data.Entities:
Mesh:
Year: 2010 PMID: 20551955 PMCID: PMC2905295 DOI: 10.1038/sj.bjc.6605744
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Comparison of demographic characteristics of British whites and British Indians in Leicester (Office for National Statistics, 2001)
|
|
| |
|---|---|---|
|
|
|
|
|
| ||
| Male | 34 977 (49) | 80 892 (48) |
|
| ||
| <44 | 52 190 (73) | 10 5873 (63) |
| 45–54 | 9671 (13) | 18 863 (11) |
| 55–64 | 5220 (7) | 15 091 (9) |
| 65–74 | 3206 (5) | 14 025 (8) |
| 75+ | 1747 (2) | 15 604 (9) |
|
| ||
| 1 (most deprived) | 41 527 (58) | 80 517 (48) |
| 2 | 18 017 (25) | 38 492 (23) |
| 3 | 9025 (13) | 30 428 (18) |
| 4 | 2733 (4) | 15 415 (9) |
| 5 (least deprived) | 732 (1) | 4604 (3) |
|
| ||
| UK | 31 271 (43) | 16 6549 (98) |
| India | 23 220 (32) | 168 (0.1) |
| Other | 17 548 (24) | 2738 (2) |
|
| ||
| Christian | 762 (1) | 10 9249 (65) |
| Hindu | 39 517 (55) | 198 (0.1) |
| Muslim | 18 180 (25) | 471 (0.3) |
| Sikh | 10 536 (15) | 147 (0.1) |
| Other/Not stated | 3038 (4) | 14 346 (35) |
Distribution of the population, and of registered cancers in Leicester by ethnic group
|
|
|
|
|---|---|---|
| British white | 16 9456 (60.6) | 4609 (69.7) |
| British Indian | 72 033 (25.7) | 742 (11.2) |
| All other ethnic groups (black, Chinese, other Asian, other white and mixed) | 38 432 (13.7) | 1123 (17.0) |
| No ethnicity recorded | 0 | 141 (2.1) |
| Total | 27 9921 (100) | 6615 (100) |
Age-standardised cancer incidence rates for (a) male and (b) female British whites and British Indians in Leicester, and Mumbai and Ahmedabad, India
|
|
|
| |||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| (a) | |||||||
| C00–C14/C30–32 | Head and neck | 103 | 15.0 (11.9–18.1) | 28 | 13.9 (8.7–19.1) | 26.2 | 29.5 |
| C15 | Oesophagus | 94 | 11.4 (8.9–13.9) | 11 | 5.1 (2.1–8.2) | 6.7 | 8.0 |
| C16 | Stomach | 114 | 12.0 (9.6–14.5) | 12 | 6.0 (2.6–9.5) | 4.6 | 2.1 |
| C18 | Colon | 174 | 18.2 (15.2– 21.3) | 20 | 9.9 (5.5–14.2) | 3.0 | 1.9 |
| C19–20 | Rectum | 101 | 11.7 (9.2–14.2) | 20 | 9.8 (5.5–14.1) | 2.6 | 2.3 |
| C22 | Liver | 21 | 2.6 (1.4–3.9) | 9 | 4.6 (1.6–7.6) | 4.5 | 1.9 |
| C25 | Pancreas | 56 | 6.2 (4.4–8.0) | 10 | 4.6 (1.7–7.6) | 2.2 | 1.1 |
| C33–34 | Lung | 440 | 50.4 (45.2–55.5) | 41 | 21.0 (14.5–27.4) | 9.7 | 11.4 |
| C61 | Prostate | 423 | 45.8 (41.0–50.6) | 63 | 32.8 (24.7–41.0) | 6.9 | 3.6 |
| C64–66/C68 | Kidney | 86 | 11.7 (9.0–14.3) | 10 | 5.2 (2.0–8.5) | 2.0 | 1.2 |
| C67 | Bladder | 108 | 11.4 (9.0–13.8) | 11 | 5.5 (2.2–8.8) | 3.8 | 2.5 |
| C70–72 | Brain | 45 | 7.5 (5.2–9.9) | 8 | 3.8 (1.2–6.6) | 3.7 | 2.5 |
| C81 | Hodgkin's disease | 11 | 2.3 (0.9–3.7) | 9 | 4.1 (1.4–6.9) | 0.9 | 0.7 |
| C82–85/C96 | Non-Hodgkin's lymphoma | 76 | 11.1 (8.4–13.8) | 20 | 10.2 (5.7–14.7) | 4.4 | 2.5 |
| C91–95 | Leukaemia | 53 | 6.7 (4.7–8.7) | 7 | 3.4 (0.9–6.0) | 4.4 | 3.1 |
| All sites (excluding non-melanoma skin cancer) | 2219 | 266.3 (254.0–278.7) | 330 | 165.4 (147.4–183.4) | 100.9 | 105.8 | |
| (b) | |||||||
| C00–C14/C30–32 | Head and neck | 41 | 4.5 (2.9–6.2) | 17 | 7.0 (3.7–10.4) | 9.4 | 7.7 |
| C15 | Oesophagus | 47 | 3.9 (2.5–5.2) | 9 | 3.9 (1.3–6.5) | 4.6 | 4.1 |
| C16 | Stomach | 54 | 4.6 (3.1–6.1) | 8 | 3.2 (1.0–5.5) | 2.3 | 1.3 |
| C18 | Colon | 193 | 15.5 (12.8–18.2) | 14 | 5.9 (2.8–9.0) | 2.4 | 1.3 |
| C19–20 | Rectum | 78 | 6.5 (4.7–8.3) | 19 | 7.8 (4.3–11.4) | 1.8 | 1.5 |
| C22 | Liver | 18 | 1.5 (0.6–2.3) | 8 | 3.4 (1.0–5.8) | 2.2 | 0.5 |
| C25 | Pancreas | 65 | 5.5 (3.9–7.2) | 6 | 2.3 (0.4–4.1) | 1.6 | 0.8 |
| C33–34 | Lung | 313 | 29.8 (25.9–33.8) | 12 | 4.9 (2.1–7.6) | 3.1 | 2.5 |
| C50 | Breast | 710 | 88.6 (81.1–96.1) | 149 | 63.0 (52.8–73.2) | 26.9 | 19.1 |
| C53 | Cervical | 65 | 12.2 (9.1–15.3) | 17 | 7.6 (4.0–11.3) | 14.5 | 13.4 |
| C54–55 | Uterus | 135 | 16.6 (13.4–19.8) | 30 | 13.1 (8.4–17.8) | 3.8 | 1.8 |
| C56 | Ovarian | 95 | 13.0 (10.1–16.0) | 29 | 12.6 (8.0–17.2) | 7.1 | 3.6 |
| C70–72 | Brain | 27 | 3.2 (1.8–4.6) | 7 | 3.2 (0.8–5.6) | 2.8 | 1.5 |
| C73 | Thyroid | 19 | 3.0 (1.5–4.5) | 7 | 3.0 (0.8–5.2) | 1.5 | 0.8 |
| C82–85/C96 | Non-Hodgkin's lymphoma | 89 | 8.9 (6.7–11.0) | 21 | 9.1 (5.2–13.0) | 2.9 | 1.2 |
| C91–95 | Leukaemia | 31 | 3.0 (1.7–4.4) | 10 | 4.4 (1.6–7.4) | 3.2 | 2.5 |
| All sites (excluding non-melanoma skin cancer) | 2390 | 258.9 (246.5–271.4) | 412 | 175.1 (158.0–192.2) | 103.7 | 81.8 | |
Abbreviation: ICD=International Classifications of Diseases.
All rates are standardised to the age distribution of the Segi standard population.
Incident rate ratios in British Indians compared with British whites in Leicester
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
|
|
|
| C00–C14/ C30–32 | Head and Neck | 0.89 (0.58–1.36) | 1.72 (0.95–3.13) | 1.09 (0.77–1.55) | 0.6 |
| C15 | Oesophagus | 0.49 (0.26–0.92) | 0.97 (0.47–2.03) | 0.64 (0.40–1.03) | 0.05 |
| C16 | Stomach | 0.46 (0.25–0.84) | 0.69 (0.31–1.47) | 0.54 (0.34–0.87) | 0.006 |
| C18 | Colon | 0.52 (0.33–0.84) | 0.38 (0.22–0.67) | 0.46 (0.32–0.66) | <0.001 |
| C19–20 | Rectum | 0.83 (0.51–1.35) | 1.19 (0.71–2.01) | 0.98 (0.69–1.40) | 0.9 |
| C22 | Liver | 1.68 (0.74–3.77) | 2.34 (0.98–5.59) | 1.95 (1.08–3.54) | 0.03 |
| C25 | Pancreas | 0.82 (0.41–1.64) | 0.52 (0.22–1.23) | 0.68 (0.40–1.15) | 0.1 |
| C33–34 | Lung | 0.40 (0.29–0.55) | 0.16 (0.09–0.29) | 0.30 (0.23–0.40) | <0.001 |
| C50 | Breast | — | 0.72 (0.60–0.86) | — | <0.001 |
| C53 | Cervical | — | 0.62 (0.36–1.07) | — | 0.07 |
| C54–55 | Uterus | — | 0.77 (0.51–1.16) | — | 0.2 |
| C56 | Ovarian | — | 0.95 (0.62–1.46) | — | 0.8 |
| C61 | Prostate | 0.76 (0.58–0.99) | — | — | 0.04 |
| C64–66/C68 | Kidney | 0.42 (0.22–0.83) | 0.15 (0.20–1.10) | 0.36 (0.19–0.68) | <0.001 |
| C67 | Bladder | 0.50 (0.27–0.94) | 0.39 (0.12–1.27) | 0.48 (0.27–0.84) | 0.005 |
| C70–72 | Brain | 0.50 (0.23–1.08) | 1.00 (0.42–2.36) | 0.66 (0.38–1.17) | 0.1 |
| C73 | Thyroid | 1.07 (0.43–2.61) | 1.16 (0.52–2.59) | 0.7 | |
| C81 | Hodgkin's disease | 1.85 (0.75–4.53) | 1.87 (0.58–5.99) | 1.84 (0.90–3.74) | 0.1 |
| C82–85/C96 | Non-Hodgkin's lymphoma | 0.83 (0.50–1.38) | 1.04 (0.63–1.70) | 0.93 (0.65–1.32) | 0.7 |
| C88–90 | Myeloma | 0.75 (0.29–1.98) | 0.94 (0.36–2.49) | 0.84 (0.43–1.68) | 0.6 |
| C91–95 | Leukaemia | 0.50 (0.22–1.11) | 1.40 (0.66–2.97) | 0.81 (0.47–1.38) | 0.4 |
| All sites (excluding non-melanoma skin cancer) | 0.61 (0.54–0.69) | 0.67 (0.61–0.76) | 0.65 (0.60–0.71) | <0.001 | |
Abbreviation: ICD=International Classifications of Diseases.
P-values are for males and females combined except for breast, prostate and gynaecological cancers.